You are here
Precision genomics for United States Air Force personnel using Cancer Risk B and Cancer Risk C
Award Information
Agency: Department of Defense
Branch: Air Force
Contract: FA864922P0256
Agency Tracking Number: FX212-CSO1-0147
Amount:
$49,955.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
AF212-CSO1
Solicitation Number:
X21.2
Timeline
Solicitation Year:
2021
Award Year:
2022
Award Start Date (Proposal Award Date):
2021-11-03
Award End Date (Contract End Date):
2022-02-07
Small Business Information
Corporation Trust Center 1209 Orange St
Wilmington, DE
19801-1120
United States
DUNS:
079605574
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Ishraq Alim
Phone: (917) 327-5278
Email: ialim@morganandmendel.com
Phone: (917) 327-5278
Email: ialim@morganandmendel.com
Business Contact
Name: Andrew Paul
Phone: (770) 656-6484
Email: morganandmendel.genomics@outlook.com
Phone: (770) 656-6484
Email: morganandmendel.genomics@outlook.com
Research Institution
N/A
Abstract
Morgan and Mendel Genomics (MMG) is a functional genomics company developing cutting edge science to identify genetic disruptions in human cells with high sensitivity and specificity, low cost, and rapid performance time. MMG’s two novel blood tests, Canc
* Information listed above is at the time of submission. *
